NMN predicts a record $496 million in 2028

Market size of China NMN ingredient health product industry from 2019 to 2023

With the increasing pursuit of health and longevity, NMN (Nicotinamide Mononucleotide) is constantly attracting widespread attention worldwide.

According to data from GlobeNewswire,

a market research company in the United States,

the global NMN raw material market sales estimated to $280 million in 2022, and by 2028,

this number expected to climb to $496 million. The compound annual growth rate is as high as 10.0%.

NMN is a naturally occurring molecule in the human body that plays multiple important functions. Multiple studies have shown that Nicotinamide Mononucleotide can increase cellular energy levels,

promote cellular metabolic activity, and thus maintain normal body functioning;

It has a positive impact on both heart and brain functions. In addition, Nicotinamide Mononucleotide also believed to help improve physical functions such as vision, hearing, and memory.

Screenshot of GlobeNewswire

NMN considered a potential anti aging stock. With the intensification of population aging, the demand for this anti-aging substance is also constantly increasing. Therefore, the development prospects of the NMN market are broad and have enormous commercial potential.

The prospect of NMN improving NAD+levels is beneficial for body function

In China, the development momentum of this market is even more rapid. According to data from iResearch Consulting,

the market size of Nicotinamide Mononucleotide based health products in China reached 5.106 billion yuan in 2020, a year-on-year increase of 34.87%.

Expected that by 2023, this growth rate will be close to 70.25%, and the market size will climb to 27.013 billion yuan.

However, despite showing strong growth momentum in the NMN market, it is still in its early stages and there are still many unresolved issues and challenges.

For example, data on the long-term safety and effectiveness of NMN still limited,

which may have an impact on further market development.

The market is experiencing strong growth

However, with the deepening of scientific research, there are currently more and more clinical trials worldwide involving safety assessment and other related functional evaluations related to NMN. According to incomplete statistics, more than ten NMN human clinical trials have been conducted from countries such as China, the United States, Japan, and India. These experimental results indicate that NMN is safe and well tolerated, and will not cause significant harmful effects.

In addition to the market promotion in the health sector, the rapid development of the NMN market also influenced by policies and regulations.

There are differences in regulatory policies and regulatory restrictions for NMN among countries,

which will have a significant impact on the development of the market.

In some countries and regions,

Nicotinamide Mononucleotide considered a dietary supplement or functional food ingredient, and its use and sales are subject to relatively loose regulations.

In other countries,

NMN is considered a drug or cosmetic raw material, and its use and sales require strict approval and supervision. Therefore, changes in policies and regulations in various countries will directly affect the expansion and development of the NMN market.

Overall, as a globally recognized billion dollar market raw material, NMN’s future development prospects are full of infinite possibilities. Whether it is in dietary supplements, health products, or the medical field,

Nicotinamide Mononucleotide may open up innovative market space and opportunities.

Looking forward to the future development of the NMN market, as well as the changes and surprises it will bring to people’s lives.